These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6547093)

  • 1. A simplified estimate of the ion-activity product of calcium phosphate in urine.
    Tiselius HG
    Eur Urol; 1984; 10(3):191-5. PubMed ID: 6547093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of estimation of the urinary ion-activity products of calcium oxalate and calcium phosphate.
    Ogawa Y
    Hinyokika Kiyo; 1993 May; 39(5):407-11. PubMed ID: 8322621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine.
    Tiselius HG; Ferraz RR; Heilberg IP
    Urol Res; 2012 Aug; 40(4):285-91. PubMed ID: 22200737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian rhythms of urinary saturation levels of calcium oxalate and calcium phosphate in normal male individuals.
    Ogawa Y
    Hinyokika Kiyo; 1993 Sep; 39(9):785-9. PubMed ID: 8213370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposed method for approximate estimates of the ion-activity products of calcium oxalate and calcium phosphate in spot-urine samples or in urine samples collected during less well defined periods of time.
    Tiselius HG
    Urolithiasis; 2013 Apr; 41(2):105-9. PubMed ID: 23503871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sample time on urinary lithogenic risk indexes in healthy and stone-forming adults and children.
    Rodriguez A; Saez-Torres C; Mir C; Casasayas P; Rodriguez N; Rodrigo D; Frontera G; Buades JM; Gomez C; Costa-Bauza A; Grases F
    BMC Urol; 2018 Dec; 18(1):116. PubMed ID: 30567525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pH on the risk of calcium oxalate crystallization in urine.
    Berg C; Tiselius HG
    Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of the risk of calcium phosphate crystallization in urine.
    Tiselius HG
    Urol Res; 1987; 15(2):79-81. PubMed ID: 3590433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of calcium phosphate crystalluria: influence of pH and osmolality and invariable presence of oxalate.
    Hallson PC; Rose GA
    Br J Urol; 1989 Nov; 64(5):458-62. PubMed ID: 2611613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical factors governing the state of saturation towards brushite and whewellite in urine of calcium stone formers.
    Ackermann D; Baumann JM
    Urol Res; 1987; 15(2):63-5. PubMed ID: 3590430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composition of Urine Collected from Non-Stone-Forming Chinese Persons during Different Short-Term Periods of the Day.
    He Z; Chang Z; An L; Lei M; Jiang Z; Ou L; Wu W; Tiselius HG
    Urol Int; 2022; 106(3):227-234. PubMed ID: 33744905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
    Tiselius HG
    Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Computer calculations on the effect of urine components on saturation relations of calcium oxalate in the urine].
    Matouschek E; Huber RD
    Urologe A; 1984 Mar; 23(2):70-6. PubMed ID: 6547011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in 24-hour urine composition between apatite and brushite stone formers.
    Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2013 Oct; 82(4):768-72. PubMed ID: 23791217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects on estimation of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Int; 1991; 47(4):255-9. PubMed ID: 1781112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple technique for the determination of urinary state of saturation with respect to brushite.
    Pak CY; Chu S
    Invest Urol; 1973 Nov; 11(3):211-5. PubMed ID: 4749421
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.
    Sakhaee K; Nicar M; Hill K; Pak CY
    Kidney Int; 1983 Sep; 24(3):348-52. PubMed ID: 6645208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphates precipitating from artificial urine and fine structure of phosphate renal calculi.
    Grases F; Sohnel O; Vilacampa AI; March JG
    Clin Chim Acta; 1996 Jan; 244(1):45-67. PubMed ID: 8919201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine calcium phosphate uroliths.
    Klausner JS; Osborne CA
    Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):171-84. PubMed ID: 3518200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.